219 related articles for article (PubMed ID: 16480269)
1. Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
Howard N; Abell C; Blakemore W; Chessari G; Congreve M; Howard S; Jhoti H; Murray CW; Seavers LC; van Montfort RL
J Med Chem; 2006 Feb; 49(4):1346-55. PubMed ID: 16480269
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based lead discovery using X-ray crystallography.
Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
[TBL] [Abstract][Full Text] [Related]
3. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
4. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
[TBL] [Abstract][Full Text] [Related]
5. Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency.
Edwards PD; Albert JS; Sylvester M; Aharony D; Andisik D; Callaghan O; Campbell JB; Carr RA; Chessari G; Congreve M; Frederickson M; Folmer RH; Geschwindner S; Koether G; Kolmodin K; Krumrine J; Mauger RC; Murray CW; Olsson LL; Patel S; Spear N; Tian G
J Med Chem; 2007 Nov; 50(24):5912-25. PubMed ID: 17985862
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
7. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
[TBL] [Abstract][Full Text] [Related]
8. Compounds binding to the S2-S3 pockets of thrombin.
Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
10. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
Gill A; Cleasby A; Jhoti H
Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
[TBL] [Abstract][Full Text] [Related]
11. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
12. Fragment shuffling: an automated workflow for three-dimensional fragment-based ligand design.
Nisius B; Rester U
J Chem Inf Model; 2009 May; 49(5):1211-22. PubMed ID: 19413347
[TBL] [Abstract][Full Text] [Related]
13. Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
Oyarzabal J; Zarich N; Albarran MI; Palacios I; Urbano-Cuadrado M; Mateos G; Reymundo I; Rabal O; Salgado A; Corrionero A; Fominaya J; Pastor J; Bischoff JR
J Med Chem; 2010 Sep; 53(18):6618-28. PubMed ID: 20722422
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex.
Nilsson JW; Kvarnström I; Musil D; Nilsson I; Samulesson B
J Med Chem; 2003 Sep; 46(19):3985-4001. PubMed ID: 12954052
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
[TBL] [Abstract][Full Text] [Related]
16. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
[TBL] [Abstract][Full Text] [Related]
17. High-throughput X-ray crystallography for drug discovery.
Blundell TL; Patel S
Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
Ahlström MM; Ridderström M; Luthman K; Zamora I
J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
[TBL] [Abstract][Full Text] [Related]
20. Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin.
Greenidge PA; Mérette SA; Beck R; Dodson G; Goodwin CA; Scully MF; Spencer J; Weiser J; Deadman JJ
J Med Chem; 2003 Apr; 46(8):1293-305. PubMed ID: 12672230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]